About Codiak BioSciences
Founded in 2015, Codiak is building a unique platform to employ exosomes as therapeutics. Exosomes are an ancient, highly evolved, and natural messenger system that cells use to communicate. Exosomes are lipid nanoparticles that have unique protein and carbohydrate molecules on their surface that allow them to traffic in the body and be taken up efficiently by cells. At Codiak, we can engineer specific messages into the exosome system, effectively hijacking their biology to define a new class of medicines.